New AI solution being tested at Umeå vaccine facility
A new AI solution for sustainable production is to be tested at Diamyd Medical's vaccine manufacturing facility in Umeå. It is hoped, once the solution has been refined, that it can be introduced in companies throughout Sweden. “This represents a unique opportunity that we do not see that often in Sweden”, says Ulf Hannelius, CEO of Diamyd Medical.